Sign in
Year 3 results and age-stratified analyses for a phase 3 trial of voretigene neparvovec in RPE65 mutation-associated inherited retinal disease
Abstract

Year 3 results and age-stratified analyses for a phase 3 trial of voretigene neparvovec in RPE65 mutation-associated inherited retinal disease

Arlene V Drack, Jean Bennett, Stephen Russell, Jennifer A Wellman, Daniel C Chung, Katherine A High, Zi-Fan Yu and Albert M Maguire
Journal of AAPOS, Vol.22(4), pp.e13-e13
08/2018
DOI: 10.1016/j.jaapos.2018.07.039

View Online

Details

Metrics

33 Record Views